vs
STANDARD BIOTOOLS INC.（LAB）与UNIVERSAL HEALTH REALTY INCOME TRUST（UHT）财务数据对比。点击上方公司名可切换其他公司
UNIVERSAL HEALTH REALTY INCOME TRUST的季度营收约是STANDARD BIOTOOLS INC.的1.3倍（$24.5M vs $19.6M），UNIVERSAL HEALTH REALTY INCOME TRUST净利率更高（17.7% vs -177.4%，领先195.1%），UNIVERSAL HEALTH REALTY INCOME TRUST同比增速更快（-0.7% vs -11.5%），过去两年UNIVERSAL HEALTH REALTY INCOME TRUST的营收复合增速更高（-1.3% vs -12.2%）
Standard BioTools（原Fluidigm公司）是一家美国生命科学工具企业，主营流式细胞术与组织成像分析用质谱流式系统，以及配套的检测试剂盒与试剂，同时供应自动化基因组分析仪器、各类微流控芯片（又称集成流体电路）及配套试剂耗材，全系列产品及应用场景均可提供定制检测方案与相关服务。
环球健康服务公司（UHS）是一家总部位于宾夕法尼亚州普鲁士国王市的美国医疗服务企业，位列财富500强，主营医院运营及各类医疗保健服务。该公司2024年公布的总营收达158亿美元。
LAB vs UHT — 直观对比
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $19.6M | $24.5M |
| 净利润 | $-34.7M | $4.3M |
| 毛利率 | 48.5% | — |
| 营业利润率 | -168.5% | 34.7% |
| 净利率 | -177.4% | 17.7% |
| 营收同比 | -11.5% | -0.7% |
| 净利润同比 | -28.8% | -7.2% |
| 每股收益（稀释后） | $-0.09 | $0.32 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | — | $24.5M | ||
| Q3 25 | $19.6M | $25.3M | ||
| Q2 25 | $21.8M | $24.9M | ||
| Q1 25 | $40.8M | $24.5M | ||
| Q4 24 | — | $24.6M | ||
| Q3 24 | $22.1M | $24.5M | ||
| Q2 24 | $22.5M | $24.7M | ||
| Q1 24 | $45.5M | $25.1M |
| Q4 25 | — | $4.3M | ||
| Q3 25 | $-34.7M | $4.0M | ||
| Q2 25 | $-33.5M | $4.5M | ||
| Q1 25 | $-26.0M | $4.8M | ||
| Q4 24 | — | $4.7M | ||
| Q3 24 | $-26.9M | $4.0M | ||
| Q2 24 | $-45.7M | $5.3M | ||
| Q1 24 | $-32.2M | $5.3M |
| Q4 25 | — | — | ||
| Q3 25 | 48.5% | — | ||
| Q2 25 | 48.8% | — | ||
| Q1 25 | 48.4% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 54.9% | — | ||
| Q2 24 | 46.1% | — | ||
| Q1 24 | 53.1% | — |
| Q4 25 | — | 34.7% | ||
| Q3 25 | -168.5% | 33.2% | ||
| Q2 25 | -118.1% | 35.6% | ||
| Q1 25 | -80.8% | 36.8% | ||
| Q4 24 | — | 37.6% | ||
| Q3 24 | -120.9% | 34.7% | ||
| Q2 24 | -134.5% | 38.7% | ||
| Q1 24 | -132.2% | 37.6% |
| Q4 25 | — | 17.7% | ||
| Q3 25 | -177.4% | 15.9% | ||
| Q2 25 | -153.7% | 18.1% | ||
| Q1 25 | -63.8% | 19.5% | ||
| Q4 24 | — | 18.9% | ||
| Q3 24 | -122.0% | 16.3% | ||
| Q2 24 | -203.3% | 21.3% | ||
| Q1 24 | -70.6% | 21.1% |
| Q4 25 | — | $0.32 | ||
| Q3 25 | $-0.09 | $0.29 | ||
| Q2 25 | $-0.09 | $0.32 | ||
| Q1 25 | $-0.07 | $0.34 | ||
| Q4 24 | — | $0.34 | ||
| Q3 24 | $-0.07 | $0.29 | ||
| Q2 24 | $-0.12 | $0.38 | ||
| Q1 24 | $-0.27 | $0.38 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $129.4M | $6.7M |
| 总债务越低越好 | — | $374.8M |
| 股东权益账面价值 | $399.7M | $152.4M |
| 总资产 | $539.6M | $564.9M |
| 负债/权益比越低杠杆越低 | — | 2.46× |
8季度趋势，按日历期对齐
| Q4 25 | — | $6.7M | ||
| Q3 25 | $129.4M | $6.9M | ||
| Q2 25 | $158.6M | $6.6M | ||
| Q1 25 | $150.9M | $7.0M | ||
| Q4 24 | — | $7.1M | ||
| Q3 24 | $210.6M | $6.4M | ||
| Q2 24 | $269.8M | $5.6M | ||
| Q1 24 | $287.1M | $7.7M |
| Q4 25 | — | $374.8M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $368.4M | ||
| Q3 24 | $55.2M | — | ||
| Q2 24 | $55.1M | — | ||
| Q1 24 | $55.0M | — |
| Q4 25 | — | $152.4M | ||
| Q3 25 | $399.7M | $158.6M | ||
| Q2 25 | $424.5M | $165.2M | ||
| Q1 25 | $454.6M | $172.2M | ||
| Q4 24 | — | $179.5M | ||
| Q3 24 | $489.3M | $181.6M | ||
| Q2 24 | $510.3M | $190.7M | ||
| Q1 24 | $577.3M | $196.5M |
| Q4 25 | — | $564.9M | ||
| Q3 25 | $539.6M | $568.0M | ||
| Q2 25 | $557.0M | $573.0M | ||
| Q1 25 | $579.6M | $573.5M | ||
| Q4 24 | — | $580.9M | ||
| Q3 24 | $681.5M | $584.3M | ||
| Q2 24 | $708.7M | $586.6M | ||
| Q1 24 | $777.7M | $596.2M |
| Q4 25 | — | 2.46× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 2.05× | ||
| Q3 24 | 0.11× | — | ||
| Q2 24 | 0.11× | — | ||
| Q1 24 | 0.10× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-22.2M | $49.1M |
| 自由现金流经营现金流 - 资本支出 | $-23.1M | — |
| 自由现金流率自由现金流/营收 | -118.1% | — |
| 资本支出强度资本支出/营收 | 4.5% | — |
| 现金转化率经营现金流/净利润 | — | 11.35× |
| 过去12个月自由现金流最近4个季度 | $-111.1M | — |
8季度趋势，按日历期对齐
| Q4 25 | — | $49.1M | ||
| Q3 25 | $-22.2M | $10.2M | ||
| Q2 25 | $-20.7M | $13.7M | ||
| Q1 25 | $-30.3M | $11.6M | ||
| Q4 24 | — | $46.9M | ||
| Q3 24 | $-27.9M | $9.9M | ||
| Q2 24 | $-39.0M | $12.1M | ||
| Q1 24 | $-62.5M | $11.7M |
| Q4 25 | — | — | ||
| Q3 25 | $-23.1M | — | ||
| Q2 25 | $-22.6M | — | ||
| Q1 25 | $-35.3M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-30.1M | — | ||
| Q2 24 | $-41.0M | — | ||
| Q1 24 | $-63.3M | — |
| Q4 25 | — | — | ||
| Q3 25 | -118.1% | — | ||
| Q2 25 | -103.6% | — | ||
| Q1 25 | -86.6% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -136.4% | — | ||
| Q2 24 | -182.2% | — | ||
| Q1 24 | -138.9% | — |
| Q4 25 | — | — | ||
| Q3 25 | 4.5% | — | ||
| Q2 25 | 8.7% | — | ||
| Q1 25 | 12.4% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 10.2% | — | ||
| Q2 24 | 8.6% | — | ||
| Q1 24 | 1.7% | — |
| Q4 25 | — | 11.35× | ||
| Q3 25 | — | 2.54× | ||
| Q2 25 | — | 3.05× | ||
| Q1 25 | — | 2.43× | ||
| Q4 24 | — | 10.06× | ||
| Q3 24 | — | 2.48× | ||
| Q2 24 | — | 2.30× | ||
| Q1 24 | — | 2.21× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
UHT
| Reportable Segment Aggregation Before Other Operating Segment | $23.1M | 94% |
| Equity Method Investment Nonconsolidated Investee Or Group Of Investees | $2.3M | 9% |
